HCWB: HCW Biologics, Inc. Company Short-Term Debt
The development of treatments for age-related pathologies is independent of economic cycles, and medical patents guarantee the value of assets for HCW Biologics Inc. (HCWB). Market price action with the 0.01 indicator highlights the risks of a narrow business profile tied to the outcomes of primary tests. Meanwhile, global geopolitical tensions complicate the conduct of international research and disrupt component supplies, hindering the entry of new therapies into the global market.
Metric breakdowns and analytics for HCW Biologics, Inc. (HCWB)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital HCW Biologics Inc.|HCWB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity HCW Biologics Inc|HCWB - Company Total Debt|Debt to Book Capitalization Ratio HCW Biologics Inc.|HCWB - Company Long-Term Liabilities|Company Current Liabilities HCW Biologics|Quick Liquidity hcwbiologics.com
- net income and valuation multiples indicators:
Initial company analysis:HCWB - hcwbiologics.com
Liquidity control is critical for HCW Biologics Inc. (HCWB), as its immunotherapy R&D processes rely on grants in the absence of operating profit. By analyzing the organization's short-term debt, an investor can see the aggregate of obligations maturing within one year, which allows for an assessment of cash gap risks and the speed of accounts payable servicing. The dynamics of this curve determine the capital stability of HCW Biologics Inc. (HCWB) during the intervals between funding rounds.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Company Short-Term Loans and Borrowings ZBIO (Zenas Corp)|IMNM: Company Short-Term Debts|Company Current Liabilities gossamerbio.com|Company Current Liabilities KALV|Company Current Liabilities Septerna, Inc. (SEPN)|Company Current Liabilities PVLA (Pieris Pharmaceuticals Inc)|SVRA (Savara Pharma) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT Therapeutics (RAPT) - Company Short-Term Debt|Short-Term Debt Aerovate Therapeutics (JBIO)|Company Short-Term Debt Aclaris Therapeutics|Company Short-Term Debt KYTX|Company Short-Term Debt Tiziana Life Sciences Ltd (TLSA)|CABA - Short-Term Debt|Company Short-Term Debts VTYX (Ventyx Bio)|Short-Term Indebtedness Theratechnologies, Inc|Avalo Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt Volume eledon.com ELDN|AGEN: Company Short-Term Debts|Company Current Liabilities Climb Bio Inc.|Company Short-Term Debt Zura Bio|aTyr Pharmaceuticals (ATYR) - Short-Term Debt Volume|Company Current Liabilities ADAG (Adagene)|IMA (ikenaoncology.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts STTK (Shattuck Labs)|Short-Term Debt Volume Equillium Inc (EQ)|CNTB - Company Short-Term Debt|IMUX (Immunic, Inc.) - Company Short-Term Indebtedness|ATRA: Company Short-Term Debts|Company Current Liabilities InflaRx|Company Current Liabilities XFOR|Adicet (ACET) - Short-Term Debt Volume|Company Short-Term Debts CELU|INMB (INmune Bio Corporation) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|KZR - Company Current Liabilities|SABS: Company Current Liabilities|Akari Therapeutics PLC (AKTX) - Company Current Liabilities|ENLV: Company Short-Term Debts|QTTB (Q32 Bio) - Company Short-Term Debt|Company Short-Term Debt GeoVax Labs, Inc.|edesabiotech.com - Current Liabilities|Company Short-Term Debts IBIO|CARM (carismatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts XTLB (XTL Biopharmaceuticals, Ltd.)|Company Short-Term Debts Bolt Biotherapeutics Inc. BOLT|APVO - Company Short-Term Debt|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Current Liabilities REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Short-Term Debt Volume CalciMedica Inc (CALI)|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Current Liabilities ITOS|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Company Short-Term Indebtedness